Eden Bio
Signal active
Organization
Contact Information
Overview
Eden Bio is a strain-engineering company with the mission of assisting fermentation businesses. With the world needing to transition away from traditional farming methods and toward a more sustainable future, Eden Bio is there to assist businesses in making that transition.
Eden Bio's team is able to optimize genetic modifications made to customer strains by using their proprietary machine-learning platform. They work across industries to help companies optimize for yield, enzymatic activity, and other factors.
The company was founded in 2021 and is based in London.
About
Industries
Biotechnology, Machine Learning, Bioinformatics
Founded
2021
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Eden Bio headquartered in Europe, operates in the Biotechnology, Machine Learning, Bioinformatics sector. The company focuses on Biotechnology and has secured $14.1M in funding across 12 round(s). With a team of 1-10 employees, Eden Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Eden Bio, raised $1.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
9
Lead Investors
0
Total Funding Amount
$1.2M
Details
1
Eden Bio has raised a total of $1.2M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 1.2M |
Investors
Eden Bio is funded by 15 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Andrew Russell | - | FUNDING ROUND - Andrew Russell | 1.2M |
| David Harding | - | FUNDING ROUND - David Harding | 1.2M |
| Eden Bio | - | FUNDING ROUND - Eden Bio | 1.2M |
| Unruly Capital | - | FUNDING ROUND - Unruly Capital | 1.2M |
Recent Activity
There is no recent news or activity for this profile.